4
Changes in Ownership
Editas Medicine, Inc. Filed Acc 0001415889-22-001224
EVP, CHIEF SCIENTIFIC OFFICER acquired 31,709 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Shearman Mark S EVP, CHIEF SCIENTIFIC OFFICER | 2022-02-10 | Grant or award | +31,709 | 73,494 | D | ||
| Derivatives | |||||||
| Shearman Mark S EVP, CHIEF SCIENTIFIC OFFICER | 2022-02-10 | Grant or award · Stock Option (right to buy) | +93,398 | 93,398 | D | ||
Loading xslF345X03/form4-02112022_010249.xml…